U.S. Markets closed
  • S&P 500

    -54.85 (-1.51%)
  • Dow 30

    -500.10 (-1.71%)
  • Nasdaq

    -161.89 (-1.51%)
  • Russell 2000

    -10.21 (-0.61%)
  • Crude Oil

    -1.49 (-1.83%)
  • Gold

    -0.30 (-0.02%)
  • Silver

    +0.30 (+1.62%)

    -0.0018 (-0.1862%)
  • 10-Yr Bond

    +0.0570 (+1.52%)
  • Vix

    -0.22 (-0.69%)

    +0.0043 (+0.3841%)

    +0.2770 (+0.1918%)

    -201.24 (-1.04%)
  • CMC Crypto 200

    +0.06 (+0.01%)
  • FTSE 100

    +12.22 (+0.18%)
  • Nikkei 225

    -484.84 (-1.83%)

Mettler-Toledo (MTD) Q4 Earnings & Sales Top Estimates, Up Y/Y

·4 min read

Mettler-Toledo International, Inc. MTD reported four-quarter 2020 adjusted earnings of $9.26 per share, which beat the Zacks Consensus Estimate by 6.2%. The bottom line also improved 19% on a year-over-year basis and 31.9% sequentially.

Net sales of $937.9 million were up 11% on a reported basis and 7% on a currency-neutral basis from the respective year-ago quarter levels. Further, the top line rose 16.2% from the prior quarter. Also, the same surpassed the Zacks Consensus Estimate of $903.9 million.

Strong performance delivered by the company across all geographies, especially in China, remained a major positive. Further, growing momentum across the Laboratory and Food Retail segments in the reported quarter drove top-line growth.

Additionally, solid customer demand along with proper execution and cost-control strategiescontributed well.

However, headwinds related to the coronavirus continued to impact the company negatively. Moreover, uncertainties due to the ongoing pandemic are likely to linger in the near term.

Nevertheless, the company’s portfolio strength, cost-cutting efforts, margin and productivity initiatives, and robust sales and marketing strategies are expected to remain tailwinds amid the COVID-related uncertainties.

The stock has returned 56.3% on a year-to-date basis compared with the industry’s rally of 38.2%.

Top Line in Detail

By Segments: The company reports under three segments, namely Laboratory Instruments, Industrial Instruments and Food Retail, which accounted for 56%, 38% and 6% of the net sales in the fourth quarter, respectively. Further, the Laboratory, Industrial and Food Retail segments witnessed year-over-year growth of 12%, 1% and 7%, respectively, in the quarter under review.

By Geography: The company reports total sales from the Americas, Europe and Asia/Rest of the World. All these regions contributed 36%, 32% and 32% to the net sales in the fourth quarter, respectively. Further, sales in Americas, Europe and Asia/Rest of the World went up 8%, 7% and 8%, respectively, on a year-over-year basis.

Operating Results

Gross margin was 59.6%, expanding 60 bps year over year.

Research & development (R&D) expenses were $39.9 million, up 12.9% from the year-ago quarter. Selling, general & administrative (SG&A) expenses increased 9.5% year over year to $226.4 million.

As a percentage of sales, R&D expenses expanded 10 bps year over year to 4.3%. Further, SG&A expenses contracted 40 bps year over year to 24.1%.

Adjusted operating margin was 31.2%, which expanded 80 bps from the prior-year quarter.

MettlerToledo International, Inc. Price, Consensus and EPS Surprise

MettlerToledo International, Inc. Price, Consensus and EPS Surprise
MettlerToledo International, Inc. Price, Consensus and EPS Surprise

MettlerToledo International, Inc. price-consensus-eps-surprise-chart | MettlerToledo International, Inc. Quote

Balance Sheet & Cash Flow

As of Dec 31, 2020, the company’s cash and cash equivalent balance was $95.2 million, down from $153.7 million on Sep 30, 2020.

Long-term debt was $1.3 billion at the end of the fourth quarter, increasing from $1.2 billion at the end of the third quarter.

Mettler-Toledo generated $250.9 million of cash from operating activities in the reported quarter, up from $225.1 million in the previous quarter. Free cash flow was $218.1 million in the reported quarter.


For first-quarter 2021, Mettler-Toledo anticipates sales growth between 11% and 13% on a year-over-year basis in local currency. The Zacks Consensus Estimate for sales is pegged at $718.2 million.

Adjusted first-quarter earnings are anticipated to be $5.55-$5.70 per share, implying a 39%-43% rise from the year-ago quarter’s reported figure. The Zacks Consensus Estimate for earnings is pegged at $6.01 per share.

For 2021, the company anticipates year-over-year sales growth of 5%-7% in local currency. The Zacks Consensus Estimate for sales is pegged at $3.27 billion.

Adjusted 2021 earnings are anticipated to be $29.20-$29.80 per share. The Zacks Consensus Estimate for the same is pegged at $28.10 per share.

Zacks Rank & Other Stocks to Consider

Mettler-Toledo currently carries a Zacks Rank #3 (Hold).

Some better-ranked stocks in the broader technology sector are Take Two Interactive TTWO, CDW Corporation CDW, and CrowdStrike CRWD. All companies carry a Zacks Rank #2 at present. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Long-term earnings growth rates for Take Two Interactive, CDW, and CrowdStrike are currently pegged at 12%, 13.1% and 25%, respectively.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

CrowdStrike Holdings Inc. (CRWD) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research